Agree it looks OK and signs for second half are positive - esp. comments about reduced capital spend.
I'd give management the benefit of doubt on underlying figures; this year's abnormal relates to costs of the Nova acquisition (+ another acquisition not made) and last year they stripped out a gain on a disposal. No evidence (yet) of repeated 'abnormal' losses.
Ann: Appendix 4D - Half Year Report, page-3
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PEA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.09 |
Change
0.005(0.46%) |
Mkt cap ! n/a | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.09 | $1.09 | $80.13K | 73.80K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 20979 | $1.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.09 | 93741 | 7 |
View Market Depth
| Last trade - 13.41pm 24/09/2019 (20 minute delay) ? |
| PEA (ASX) Chart |
Day chart unavailable
